Clinical trials sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Shenzhen Salubris Pharmaceuticals Co., Ltd.

• A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension
  NCT07654140 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
  NCT07579936 · Phase: Phase 2 · Ages: 45 Years to 80 Years · Sex: Female · 1 location
• SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
  NCT07051603 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Shenzhen Salubris Pharmaceuticals Co., Ltd. recruiting for?

Shenzhen Salubris Pharmaceuticals Co., Ltd. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.